Airway hyper- or hyporeactivity to inhaled spasmogens 24 h after ovalbumin challenge of sensitized guinea-pigs

British Journal of Pharmacology
C A Lewis, K J Broadley

Abstract

1. The aim of this study was to determine whether an inhalation of ovalbumin (OA, 10 or 20 mg ml-1) by conscious OA-sensitized guinea-pigs leads to airway hyperreactivity to spasmogens 24 h later. In contrast to most previous studies, the spasmogens (5-HT, methacholine (MCh), U-46619 and adenosine) were administered by inhalation and airway function was measured in conscious guinea-pigs. 2. Guinea-pigs were sensitized by i.p. injection of 10 micrograms OA and 100 mg aluminium hydroxide in 1 ml normal saline; 14-21 days later they were exposed to an inhalation of 5-HT, MCh, U-46619 or adenosine. Specific airway conductance (sGaw) was measured in conscious animals by whole body plethysmography. The spasmogens caused bronchoconstriction, measured as a reduction in sGaw from the pre-inhalation basal values. Dose-related bronchoconstrictions were observed with 5-HT, MCh and U-46619. 3. The effect of an ovalbumin macroshock challenge upon the responses to each spasmogen were examined by giving an inhalation of aerosolized OA at 24 h (or 7 days in the cause of adenosine) after an initial spasmogen challenge. Eighteen to twenty-four hours after the OA macroshock, the same guinea-pigs were exposed to a repeated inhalation of 5-HT, MCh, ...Continue Reading

References

Feb 1, 1978·Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology·H L HahnJ A Nadel
Aug 1, 1992·British Journal of Pharmacology·J R Thorne, K J Broadley
May 1, 1992·Journal of Pharmacological and Toxicological Methods·D RaeburnM E Villamil
Jun 1, 1992·The American Review of Respiratory Disease·G L JonesP M O'Byrne
Jun 1, 1992·The American Review of Respiratory Disease·J C KipsR A Pauwels
Nov 1, 1991·Journal of Pharmacological Methods·D I BallA Newberry
Mar 1, 1991·The American Review of Respiratory Disease·E E Daniel, P O'Byrne
Mar 1, 1990·Journal of Pharmacological Methods·J P TarayreJ Tisne-Versailles
Feb 1, 1986·Lancet·P J Barnes
Sep 1, 1989·Journal of Applied Physiology·K IshidaR R Schellenberg
Feb 28, 1989·European Journal of Pharmacology·L DaffonchioB J Whittle
Aug 1, 1989·The American Review of Respiratory Disease·G D PhillipsS T Holgate
Jul 1, 1988·British Journal of Pharmacology·L DaffonchioB J Whittle
May 1, 1988·Journal of Pharmacological Methods·D A Griffiths-JohnsonM McDermott
Mar 1, 1987·Journal of Pharmacological Methods·A N Payne, G de Nucci
Sep 1, 1985·Clinical Allergy·S R Durham, A B Kay
Aug 1, 1993·The American Review of Respiratory Disease·T R HsiueJ Solway
Feb 1, 1994·American Journal of Respiratory and Critical Care Medicine·J R Thorne, K J Broadley
Aug 1, 1993·The American Review of Respiratory Disease·C G WangJ G Martin
Feb 1, 1958·The American Journal of Physiology·M O AMDUR, J MEAD

❮ Previous
Next ❯

Citations

Dec 10, 2009·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·P SeguraL M Montaño
Sep 6, 2000·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·J R Fozard, J P Hannon
Jun 26, 1998·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·H Danahay, K J Broadley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.